0001209191-22-011745.txt : 20220222
0001209191-22-011745.hdr.sgml : 20220222
20220222170121
ACCESSION NUMBER: 0001209191-22-011745
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220217
FILED AS OF DATE: 20220222
DATE AS OF CHANGE: 20220222
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Agopyan Nadia
CENTRAL INDEX KEY: 0001784758
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37939
FILM NUMBER: 22659161
MAIL ADDRESS:
STREET 1: C/O MARKER THERAPEUTICS, INC.
STREET 2: 3200 SOUTHWEST FREEWAY, SUITE 2240
CITY: HOUSTON
STATE: TX
ZIP: 77027
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Marker Therapeutics, Inc.
CENTRAL INDEX KEY: 0001094038
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 880277072
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3200 SOUTHWEST FREEWAY
STREET 2: SUITE 2500
CITY: HOUSTON
STATE: TX
ZIP: 77027
BUSINESS PHONE: (713) 400-6400
MAIL ADDRESS:
STREET 1: 3200 SOUTHWEST FREEWAY
STREET 2: SUITE 2500
CITY: HOUSTON
STATE: TX
ZIP: 77027
FORMER COMPANY:
FORMER CONFORMED NAME: TAPIMMUNE INC.
DATE OF NAME CHANGE: 20170629
FORMER COMPANY:
FORMER CONFORMED NAME: TAPIMMUNE INC
DATE OF NAME CHANGE: 20070628
FORMER COMPANY:
FORMER CONFORMED NAME: GENEMAX CORP
DATE OF NAME CHANGE: 20020718
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-02-17
0
0001094038
Marker Therapeutics, Inc.
MRKR
0001784758
Agopyan Nadia
C/O MARKER THERAPEUTICS, INC.
3200 SOUTHWEST FREEWAY, SUITE 2500
HOUSTON
TX
77027
0
1
0
0
VP, Regulatory Affairs
Employee Stock Option (right to buy)
0.46
2022-02-17
4
A
0
40000
0.00
A
2032-02-17
Common Stock
40000
40000
D
This option vests in equal monthly installments over a four year period commencing on March 17, 2022 subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date.
/s/ Michael Loiacono, Attorney-in-Fact
2022-02-22